1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces Analysis
5.3 Demand & Supply: Gap Analysis
5.4 Pricing analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition landscape
5.7 Upcoming Trends
6. Global Tonsil Cancer Market by Type
6.1 Squamous cell carcinoma
6.2 Salivary gland cancer
6.3 Lymphoma
6.4 Mucosal melanoma
6.5 Sarcomas
6.5.1 Chondsarcoma
6.5.2 Liposarcoma
6.5.3 Synovial sarcoma
6.5.4 Others
6.6 Malignant fibrous histiocytoma
6.7 Peripheral Neuroectodermal Tumor (PNET)
6.8 Others
7. Global Tonsil Cancer Market by Diagnosis
7.1 Physical exam
7.2 Imaging tests
7.1.1 Computerized Tomography (CT)
7.1.2 Magnetic Resonance Imaging (MRI)
7.1.3 Positron Emission Tomography (PET)
7.1.4 Others
7.3 Removing a sample of tissue for testing
7.4 Others
8. Global Tonsil Cancer Market by Treatment
8.1 Surgery
8.1.1 Transoral surgery
8.1.2 Transoral robotic surgery
8.1.3 Open surgery
8.1.4 Reconstructive surgery
8.1.5 Others
8.2 Radiation therapy
8.2.1 External Beam Radiation Therapy
8.2.2 Internal Radiation Therapy
8.2.3 Others
8.3 Chemotherapy
8.3.1 Alkylating Agents
8.3.2 Plant Alkaloids
8.3.4 Antitumor Antibiotics
8.3.5 Antimetabolites
8.3.6 Topoisomerase Inhibitors
8.3.7 Miscellaneous Antineoplastics
8.3.8 Others
8.4 Rehabilitation
8.5 Others
9. Global Tonsil Cancer Market by End User
9.1 Hospital and clinics
9.2 Medical research centers
9.3 Academic institutes
9.4 Others
10. Global Tonsil Cancer Market by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 The US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of Asia
10.5 Pacific
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Egypt
10.6.4 Rest of the Middle East & Africa
11. Competitive Landscape
12. Company Profile
13. Conclusion
13.1 Key findings
13.1.1 From CEO’s viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Tonsil Cancer Market
14. Appendix